Are you Dr. Levesque?
Join over one million U.S. Physicians, Nurse Practitioners and PAs, already on Doximity.
- Gain access to free telehealth tools, such as our "call shielding" and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
You already have 63 invites waiting! - Read the latest clinical news, personalized to your specialty.
Office
5889 Forbes Avenue, Suite 220
Pittsburgh, PA 15217Phone+1 412-586-3350Fax+1 412-386-3540
Summary
- Dr. Marc Levesque, MD is a rheumatologist in Pittsburgh, Pennsylvania. He is currently licensed to practice medicine in Pennsylvania. He is affiliated with Veterans Affairs Pittsburgh Healthcare System and is an Associate Professor at University of Pittsburgh School of Medicine.
Education & Training
- Duke University HospitalFellowship, Rheumatology, 1993 - 1998
- Duke University HospitalResidency, Internal Medicine, 1989 - 1992
- Yale School of MedicineClass of 1989
Certifications & Licensure
- PA State Medical License 2008 - 2022
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2011
- Fellow American College of Rheumatology
Clinical Trials
- Nitric Oxide, LPS and the Pathogenesis of Asthma Phase 1 Start of enrollment: 2003 May 01
- Human Tumor Necrosis Factor Alpha (TNFa)-Induced Pre-B Cell Bone Marrow Emigrants Start of enrollment: 2009 Nov 01
Publications & Presentations
PubMed
- 10 citationsLung gene expression and single cell analyses reveal two subsets of idiopathic pulmonary fibrosis (IPF) patients associated with different pathogenic mechanisms.Jozsef Karman, Jing Wang, Corneliu A Bodea, Sherry Cao, Marc C. Levesque
Plos One. 2021-03-23 - 15 citationsDiminished cytokine-induced Jak/STAT signaling is associated with rheumatoid arthritis and disease activityJason Ptacek, Rachael E. Hawtin, Dongmei Sun, Brent Louie, Erik Evensen
Plos One. 2021-01-14 - Response to: 'Can IL-1 be used as a target for osteoarthritis?' by Cheng et al.M. Kloppenburg, Marc C. Levesque
Annals of the Rheumatic Diseases. 2020-07-01